Tearsheet
Investment Highlights Market Valuation Price Chart Business Description Interactive Breakdown Latest Trefis Analyses Better Bets vs. AMED Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Amedisys (AMED)

Market Price (9/4/2025): $100.985 | Market Cap: $3.3 Bil
Sector: Health Care | Industry: Health Care Services

Amedisys (AMED)

Market Price (9/4/2025): $100.985
Market Cap: $3.3 Bil
Sector: Health Care
Industry: Health Care Services

Investment Highlights

0 Attractive yield
FCF Yield is 7.1%		  
0 Attractive yield
FCF Yield is 7.1%

Market Valuation

 9/4/252024202320222021
Share Price CYE$100.98$90.79$95.06$83.54$161.88
Market Cap CYE ($ Bil)3.33.03.12.75.3
Total Debt ($ Bil)0.50.50.50.50.5
Total Cash ($ Bil)0.30.30.10.00.0
Enterprise Value ($ Bil)3.43.53.63.25.8
Valuation Ratios     
P/S TTM1.41.31.41.22.4
P/EBIT TTM18.825.443.714.918.2
P/E TTM38.768.7-317.922.925.3
Sector Ratios     
P/S TTM (Sector)3.84.14.54.56.7
P/EBIT TTM (Sector)4.30.4-1.9-1.2-0.4
P/E TTM (Sector)-1.8-2.2-3.4-2.2-2.3
 9/4/2520242023
Share Price CYE$100.98$90.79$95.06
Market Cap CYE ($ Bil)3.33.03.1
Total Debt ($ Bil)0.50.50.5
Total Cash ($ Bil)0.30.30.1
Enterprise Value ($ Bil)3.43.53.6
Valuation Ratios   
P/S TTM1.41.31.4
P/EBIT TTM18.825.443.7
P/E TTM38.768.7-317.9
Sector Ratios   
P/S TTM (Sector)3.84.14.5
P/EBIT TTM (Sector)4.30.4-1.9
P/E TTM (Sector)-1.8-2.2-3.4

Market Cap Chart

Business Description

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. Show more

Price Returns Compared

Expand for Detailed View

 202020212022202320242025Total [1]
Returns
AMED Return76%-45%-48%14%-4%11%-39%
Peers Return0%33%-23%10%11%21%53%
S&P 500 Return16%27%-19%24%23%10%100%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: THC, CHE, NHC, WOOF, CVS. See AMED Returns vs. Peers.
[3] 2025 data is for the year up to 9/3/2025 (YTD)

Better Bets than Amedisys (AMED)

 AMEDBetter Performance than AMED
MetricValueIndustry (Health Care Services)
Rev Chg LTM4.9%CVS (5.0%), CI (24.6%), LH (8.0%), DGX (12.6%), DVA (5.1%)
Rev Chg 3Y Avg2.7%CVS (8.1%), CI (13.2%), LH (4.2%), DVA (4.2%), HIMS (76.3%)
Op Mgn LTM9.4%DGX (14.0%), DVA (15.0%), CHE (15.7%), SHC (27.8%), CRVL (13.9%)
CFO/Rev LTM10.0%LH (12.6%), DGX (15.9%), DVA (14.1%), HIMS (13.0%), CHE (14.7%)
FCF/Rev LTM9.7%DGX (11.6%), DVA (9.8%), CHE (12.7%), SHC (10.0%), CRVL (10.7%)
Total Yield2.6%CVS (9.3%), CI (8.1%), LH (4.4%), DGX (6.5%), DVA (8.0%)
 AMEDBetter Performance than AMED
MetricValueAll Other Sectors
Rev Chg LTM4.9%NVDA (71.6%), MSFT (14.9%), AAPL (6.0%), GOOGL (13.1%), AMZN (10.9%)
Rev Chg 3Y Avg2.7%NVDA (92.0%), MSFT (12.5%), GOOGL (10.2%), AMZN (11.3%), META (13.0%)
Op Mgn LTM9.4%NVDA (58.1%), MSFT (45.6%), AAPL (31.9%), GOOGL (32.7%), AMZN (11.4%)
CFO/Rev LTM10.0%NVDA (46.6%), MSFT (48.3%), AAPL (26.6%), GOOGL (36.0%), AMZN (18.1%)
FCF/Rev LTM9.7%NVDA (43.6%), MSFT (25.4%), AAPL (23.5%), GOOGL (18.0%), META (30.7%)
Total Yield2.6%MSFT (3.4%), AAPL (3.3%), GOOGL (4.9%), AMZN (2.9%), META (3.9%)

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Amedisys Earnings Notes  
2Amedisys vs T-Mobile US: Which Is A Better Investment?Counter-Intuitive Comparisons 
3Amedisys vs HCA Healthcare: Which Is A Better Investment?Counter-Intuitive Comparisons 
4Amedisys vs Quest Diagnostics: Which Is A Better Investment?Counter-Intuitive Comparisons 
5Better Bet Than AMED Stock: Pay Less Than Amedisys To Get More From ACN, SO   
6Better Bet Than AMED Stock: Pay Less Than Amedisys To Get More From HCA, UTHR   
7Better Bet Than AMED Stock: Pay Less Than Amedisys To Get More From DVA   
8Why Amedisys Stock Moved: AMED Stock Has Lost 38% Since 2021 Fiscal End, Primarily Due To Unfavorable Change In Revenues  
9AMED Dip Buy Analysis  
10Amedisys Total Shareholder Return (TSR): -4.5% in 2024 and -17.5% 3-yr compounded annual returns (below peer average)  
11ARTICLES  
12Stellar Sales Growth Trend Makes DexCom Stock A Wise Bet March 16th, 2022
13Can Amedisys Stock Rebound After A 5% Fall In A Week? September 24th, 2021
14Will Amedisys Stock Rebound After Hitting Its 52-Week Low? August 24th, 2021
15Despite A Q3 Beat The Rally In Amedisys Stock Appears Overdone October 29th, 2020
Title
0DASHBOARDS
1Stellar Sales Growth Trend Makes DexCom Stock A Wise Bet
2Can Amedisys Stock Rebound After A 5% Fall In A Week?
3Will Amedisys Stock Rebound After Hitting Its 52-Week Low?
4Despite A Q3 Beat The Rally In Amedisys Stock Appears Overdone
5ARTICLES
6Amedisys Earnings Notes
7Amedisys vs T-Mobile US: Which Is A Better Investment?
8Amedisys vs HCA Healthcare: Which Is A Better Investment?
9Amedisys vs Quest Diagnostics: Which Is A Better Investment?
10Better Bet Than AMED Stock: Pay Less Than Amedisys To Get More From ACN, SO 
11Better Bet Than AMED Stock: Pay Less Than Amedisys To Get More From HCA, UTHR 
12Better Bet Than AMED Stock: Pay Less Than Amedisys To Get More From DVA 
13Why Amedisys Stock Moved: AMED Stock Has Lost 38% Since 2021 Fiscal End, Primarily Due To Unfavorable Change In Revenues
14AMED Dip Buy Analysis
15Amedisys Total Shareholder Return (TSR): -4.5% in 2024 and -17.5% 3-yr compounded annual returns (below peer average)

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1EAFGrafTech International804.0%-47.2%
2RLMDRelmada Therapeutics122.3%182.7%
3XELAExela Technologies109.6%-95.5%
4PSNYWPolestar Automotive UK96.2%141.5%
5TKCMToken Communities82.8%-64.7%
6PHJMFPT Hanjaya Mandala Sampoerna66.7%34.8%
7ANGGFAngang Steel61.2%25.0%
8DTNOFDNO49.5%141.9%
9BWBabcock & Wilcox Enterprises48.5%54.9%
10MDBMongoDB46.0%34.4%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1COSGGrand Gallery-100.0%�
2PTLKFPT Lippo Karawaci-95.2%-94.7%
3NXTTNext Technology-74.5%-89.4%
4SCGYScientific Energy-72.7%-26.9%
5MGAWFMegaworld-71.0%-71.0%
6TTOOT2 Biosystems-67.7%-99.0%
7PTTMFPT Timah-62.8%-83.1%
8PIGEFPigeon-62.4%-62.4%
9NEGGNewegg Commerce-53.8%290.6%
10PTJSFPT Jasa Marga-50.9%-50.9%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1MMEXMMEX Resources∞%-50.0%
2TAWNFThai Airways International3674.5%3400.0%
3NOKPFNok Airlines2400.0%81.8%
4AYRWFAyr Wellness509.5%-94.6%
5XELAExela Technologies379.0%-95.5%
6SRNESorrento Therapeutics233.3%900.0%
7PGENPrecigen169.9%324.1%
8TLSTelos154.7%89.2%
9SATSEchoStar142.7%179.1%
10RLMDRelmada Therapeutics139.0%182.7%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1COSGGrand Gallery-100.0%�
2PTLKFPT Lippo Karawaci-95.2%-94.7%
3TTOOT2 Biosystems-94.8%-99.0%
4NXTTNext Technology-86.5%-89.4%
5OTRKOntrak-78.2%-96.6%
6SCGYScientific Energy-72.7%-26.9%
7PPCBPropanc Biopharma-72.1%-79.1%
8MGAWFMegaworld-71.0%-71.0%
9PTTMFPT Timah-62.8%-83.1%
10PIGEFPigeon-62.4%-62.4%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1EAFGrafTech International804.0%-47.2%
2RLMDRelmada Therapeutics122.3%182.7%
3XELAExela Technologies109.6%-95.5%
4PSNYWPolestar Automotive UK96.2%141.5%
5TKCMToken Communities82.8%-64.7%
6PHJMFPT Hanjaya Mandala Sampoerna66.7%34.8%
7ANGGFAngang Steel61.2%25.0%
8DTNOFDNO49.5%141.9%
9BWBabcock & Wilcox Enterprises48.5%54.9%
10MDBMongoDB46.0%34.4%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1COSGGrand Gallery-100.0%�
2PTLKFPT Lippo Karawaci-95.2%-94.7%
3NXTTNext Technology-74.5%-89.4%
4SCGYScientific Energy-72.7%-26.9%
5MGAWFMegaworld-71.0%-71.0%
6TTOOT2 Biosystems-67.7%-99.0%
7PTTMFPT Timah-62.8%-83.1%
8PIGEFPigeon-62.4%-62.4%
9NEGGNewegg Commerce-53.8%290.6%
10PTJSFPT Jasa Marga-50.9%-50.9%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Amedisys

Financials

AMEDTHCCHENHCWOOFCVSMedian
NameAmedisys Tenet He.Chemed National.Petco He.CVS Heal. 
Mkt Price-185.35464.00112.533.6274.09112.53
Mkt Cap3.316.96.81.71.093.45.1
Rev LTM2,40220,6882,4891,4586,045378,9604,267
Op Inc LTM2263,2373921178110,898309
FCF LTM2341,553315119595,941275
FCF 3Y Avg1411,468275825110,491208
CFO LTM2392,4653661491878,760303
CFO 3Y Avg1502,30333011023713,234283

Growth & Margins

AMEDTHCCHENHCWOOFCVSMedian
NameAmedisys Tenet He.Chemed National.Petco He.CVS Heal. 
Rev Chg LTM4.9%-1.1%8.5%23.8%-2.8%5.0%5.0%
Rev Chg 3Y Avg2.7%2.7%5.2%11.1%0.8%8.1%4.0%
Rev Chg Q5.2%3.2%9.8%28.7%-2.3%7.0%6.1%
QoQ Delta Rev Chg LTM1.3%0.8%2.4%6.1%-0.6%1.6%1.5%
Op Mgn LTM9.4%15.6%15.7%8.0%1.3%2.9%8.7%
Op Mgn 3Y Avg9.0%13.5%15.3%5.7%1.3%3.8%7.4%
QoQ Delta Op Mgn LTM0.2%0.7%0.5%0.4%0.7%0.2%0.5%
CFO/Rev LTM10.0%11.9%14.7%10.2%3.1%2.3%10.1%
CFO/Rev 3Y Avg6.4%11.2%14.2%8.7%3.9%3.8%7.6%
FCF/Rev LTM9.7%7.5%12.7%8.2%1.0%1.6%7.8%
FCF/Rev 3Y Avg6.0%7.1%11.8%6.4%0.8%3.0%6.2%

Valuation

AMEDTHCCHENHCWOOFCVSMedian
NameAmedisys Tenet He.Chemed National.Petco He.CVS Heal. 
Mkt Cap3.316.96.81.71.093.45.1
P/S1.40.82.71.20.20.21.0
P/EBIT18.84.416.511.710.99.111.3
P/E38.711.422.016.6-35.817.717.1
P/CFO13.96.918.611.75.410.711.2
Total Yield2.6%8.8%4.9%8.2%-2.8%9.3%6.5%
Dividend Yield0.0%0.0%0.3%2.2%0.0%3.6%0.2%
FCF Yield 3Y Avg4.5%12.0%3.6%5.5%3.3%12.5%5.0%
D/E0.10.80.00.12.90.90.5
Net D/E0.00.6-0.0-0.02.70.70.3

Returns

AMEDTHCCHENHCWOOFCVSMedian
NameAmedisys Tenet He.Chemed National.Petco He.CVS Heal. 
1M Rtn-17.2%11.2%19.0%24.0%18.6%18.6%
3M Rtn-7.9%-18.3%8.1%-2.4%17.8%7.9%
6M Rtn-51.1%-20.9%22.9%47.5%17.8%22.9%
12M Rtn-11.8%-20.5%-16.0%13.5%35.4%11.8%
3Y Rtn-232.2%-0.4%77.5%-75.3%-16.6%-0.4%
1M Excs Rtn-14.4%8.4%16.1%21.1%15.8%15.8%
3M Excs Rtn-0.9%-26.6%1.2%-10.0%9.7%0.9%
6M Excs Rtn-39.1%-31.0%12.4%36.6%6.9%12.4%
12M Excs Rtn--0.9%-33.3%-29.9%2.1%20.6%-0.9%
3Y Excs Rtn-140.0%-55.5%23.2%-129.0%-71.6%-55.5%

Comparison Analyses

Title
0Amedisys vs. Tenet Healthcare: With Return Forecast Of 7.3%, Amedisys Is A Better Bet
1AMED or CHE - With 25% Return Forecast, CHE Probably Deserves Your Money
2Amedisys vs. Paycom Software: With Return Forecast Of 99%, Paycom Software Is A Better Bet
3Amedisys vs. Monolithic Power Systems: With Return Forecast Of 48%, Monolithic Power Systems Is A Better Bet
4Amedisys vs. CoStar Group: With Return Forecast Of 79%, CoStar Group Is A Better Bet
5Amedisys vs. DexCom: With Return Forecast Of 93%, DexCom Is A Better Bet
6Amedisys vs. Veeva Systems: With Return Forecast Of 91%, Veeva Systems Is A Better Bet
7Amedisys vs. MSCI: With Return Forecast Of 47%, Amedisys Is A Better Bet
8Amedisys vs Marriot Vacations Worldwide: Similar Market Cap; Which Stock Is A Better Bet?
9Amedisys vs Beyond Meat: Similar Market Cap; Which Stock Is A Better Bet?

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date7/30/20254/24/20252/27/202511/7/20247/25/20244/25/20242/22/202410/25/20237/27/20235/4/20232/16/202310/27/2022
Key Financials Quarterly            
Total Revenue622595598588591571571556553556562558
Ebitda7011335272505260-40576458
Operating Income736046476452464757434642
Net Income2861-201732141926-80253226
EPS0.851.86-0.620.520.990.440.590.80-2.460.780.980.79
Key Financials TTM            
Total Revenue TTM2,4022,3722,3482,3212,2902,2512,2362,2282,2292,2342,2232,220
Ebitda TTM239240177226234122129140138245253259
Operating Income TTM226217210209209202193194189179184186
Net Income TTM8690438392-21-1032112119121
Growth Rates Quarterly            
Total Revenue Growth5.2%4.1%4.8%5.7%6.9%2.7%1.6%-0.3%-0.9%2.0%0.5%0.8%
EBITDA Growth-2.5%125.9%-93.9%-13.7%279.2%-11.5%-18.4%5.1%-159.7%-13.0%-7.8%-24.9%
Operating Income Growth13.4%15.0%1.4%-0.4%12.0%21.3%-1.5%12.5%20.2%-10.1%-4.0%-26.1%
Net Income Growth-13.1%323.7%-205.5%-34.9%140.2%-43.0%-39.1%1.2%-371.4%-20.3%-6.8%-43.0%
Margins Quarterly            
EBITDA Margin11.3%19.0%0.5%8.9%12.2%8.8%9.1%10.9%-7.3%10.2%11.3%10.3%
Operating Income Margin11.7%10.1%7.7%8.0%10.8%9.2%8.0%8.5%10.4%7.7%8.2%7.5%
Net Income Margin4.5%10.3%-3.4%2.9%5.5%2.5%3.4%4.7%-14.5%4.5%5.6%4.6%
Cash & Debt            
Total Cash3372853032451501081267895494118
Total Debt451452459468475482487490487485538562
Net Debt / (Cash)113167156222325374361412391436497544
Cash Flows Quarterly            
FCF from Operations67-47010652-760-10612641-14
Cash Flows TTM            
FCF from Operations TTM2392252222129610513711811411113398
Returns to Shareholders Quarterly            
Dividends000000000000
Share Repurchases-0-011-0-021-0-003
Return on Invested Capital (ROIC) Quarterly            
ROIC154.5%97.5%118.3%48.2%52.2%30.0%32.9%30.9%58.5%28.4%28.4%22.5%
Return on Invested Capital (ROIC) TTM            
ROIC TTM109.5%74.0%59.4%57.7%41.2%54.1%53.5%1.4%1.4%30.1%27.1%24.7%

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Home Health1,4041,3621,3541,2491,256
Hospice799788792750617
High Acuity Care19124  
Personal Care1561657282
Other000  
Total2,2362,2232,2142,0721,956


Operating Income by Segment
$ Mil20242023202220212020
Home Health233233272225199
Hospice190156172184143
Personal Care25468
High Acuity Care-26-27-7  
Other-243-186-189-196-173
Total156181252219177


Price Behavior

AMED Betas & Captures as of 8/31/2025

 1M2M3M6M1Y3Y
Beta-0.06-0.070.070.100.110.37
Up Beta-0.01-0.17-0.180.080.140.38
Down Beta0.340.330.130.130.090.43
Up Capture1%11%31%13%6%7%
Bmk +ve Days10223571142415
Stock +ve Days6162966130373
Down Capture-49%-54%-8%3%10%69%
Bmk -ve Days11192754106334
Stock -ve Days4142146101350

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/29/20251.2%1.8%3.6%
2/26/20250.1%0.5%1.5%
11/6/2024-0.9%-7.4%-12.0%
7/24/20240.2%0.5%-0.1%
2/21/20241.0%-0.1%-1.6%
10/24/2023-0.7%-0.7%1.9%
7/26/20230.7%2.5%3.6%
5/3/20232.3%-5.9%1.1%
...
SUMMARY STATS   
# Positive1198
# Negative91112
Median Positive1.2%6.2%3.6%
Median Negative-4.8%-5.9%-8.4%
Max Positive9.7%19.9%24.1%
Max Negative-21.9%-27.8%-26.9%

Industry Resources

External Quote Links


Prefer one of these to Trefis? Tell us why.